AAAAAA
Results:
1-9
|
Results: 9
Authors:
Lucas, KH
Kaplan-Machlis, B
Citation: Kh. Lucas et B. Kaplan-machlis, Orlistat - A novel weight loss therapy, ANN PHARMAC, 35(3), 2001, pp. 314-328
Authors:
Hogan, WJ
Kahrilas, PJ
Fass, R
Kaplan-Machlis, B
Morreale, AP
Citation: Wj. Hogan et al., Efficient and effective treatment of gastroesophageal reflux disease, FORMULARY, 35, 2000, pp. S3-S25
Authors:
Kaplan-Machlis, B
Spiegler, GE
Zodet, MW
Revicki, DA
Citation: B. Kaplan-machlis et al., Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia, ARCH FAM M, 9(7), 2000, pp. 624-630
Authors:
Lucas, KH
Kaplan-Machlis, B
Citation: Kh. Lucas et B. Kaplan-machlis, More about orlistat, PHARMACOTHE, 20(7), 2000, pp. 872-873
Authors:
Kaplan-Machlis, B
Klostermeyer, BS
Citation: B. Kaplan-machlis et Bs. Klostermeyer, The cyclooxygenase-2 inhibitors: Safety and effectiveness, ANN PHARMAC, 33(9), 1999, pp. 979-988
Authors:
Wandstrat, TL
Kaplan-Machlis, B
Temple, ME
Nahata, MC
Citation: Tl. Wandstrat et al., Tetravalent rotavirus vaccine, ANN PHARMAC, 33(7-8), 1999, pp. 833-839
Authors:
Kaplan-Machlis, B
Klostermeyer, BS
Citation: B. Kaplan-machlis et Bs. Klostermeyer, Cyclooxygenase-2 inhibitors (vol 33, pg 979, 1999), ANN PHARMAC, 33(12), 1999, pp. 1376-1376
Authors:
Kaplan-Machlis, B
Spiegler, GE
Revicki, DA
Citation: B. Kaplan-machlis et al., Health-related quality of life in primary care patients with gastroesophageal reflux disease, ANN PHARMAC, 33(10), 1999, pp. 1032-1036
Authors:
Swain, R
Kaplan-Machlis, B
Citation: R. Swain et B. Kaplan-machlis, Magnesium for the next millennium, SOUTH MED J, 92(11), 1999, pp. 1040-1047
Risultati:
1-9
|